Ascentage Pharma, a clinical-stage Chinese biotech developing novel therapies for cancer, hepatitis B, and age-related diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Ascentage's lead drug olverembatinib, a...read more
Helio Corporation, which designs, assembles, and tests space flight equipment, filed on Friday with the SEC to raise up to $15 million in an NYSE American uplisting. It is currently listed on the OTC Pink under the symbol HLEO The Berkeley, CA-based company...read more
Park Ha Biological Technology, which sells skincare and cosmetic products in China, raised $4.8 million by offering 1.2 million shares at $4, the low end of the range of $4 to $6. ...read more
Cancer and HBV biotech Ascentage Pharma files for a $100 million US IPO
Ascentage Pharma, a clinical-stage Chinese biotech developing novel therapies for cancer, hepatitis B, and age-related diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Ascentage's lead drug olverembatinib, a...read more
Space flight equipment provider Helio files and sets terms for $15 million NYSE American uplisting
Helio Corporation, which designs, assembles, and tests space flight equipment, filed on Friday with the SEC to raise up to $15 million in an NYSE American uplisting. It is currently listed on the OTC Pink under the symbol HLEO The Berkeley, CA-based company...read more
Chinese skincare product company Park Ha prices US IPO at $4, the low end of the range
Park Ha Biological Technology, which sells skincare and cosmetic products in China, raised $4.8 million by offering 1.2 million shares at $4, the low end of the range of $4 to $6. ...read more